These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Advancements in the management of pancreatic cancer: 2013. Saif MW JOP; 2013 Mar; 14(2):112-8. PubMed ID: 23474549 [TBL] [Abstract][Full Text] [Related]
3. Combined sonodynamic and antimetabolite therapy for the improved treatment of pancreatic cancer using oxygen loaded microbubbles as a delivery vehicle. McEwan C; Kamila S; Owen J; Nesbitt H; Callan B; Borden M; Nomikou N; Hamoudi RA; Taylor MA; Stride E; McHale AP; Callan JF Biomaterials; 2016 Feb; 80():20-32. PubMed ID: 26702983 [TBL] [Abstract][Full Text] [Related]
4. Induction of pancreatic cancer cell apoptosis, invasion, migration, and enhancement of chemotherapy sensitivity of gemcitabine, 5-FU, and oxaliplatin by hnRNP A2/B1 siRNA. Gu WJ; Liu HL Anticancer Drugs; 2013 Jul; 24(6):566-76. PubMed ID: 23525071 [TBL] [Abstract][Full Text] [Related]
5. Cell death in response to antimetabolites directed at ribonucleotide reductase and thymidylate synthase. Asuncion Valenzuela MM; Castro I; Gonda A; Diaz Osterman CJ; Jutzy JM; Aspe JR; Khan S; Neidigh JW; Wall NR Onco Targets Ther; 2015; 8():495-507. PubMed ID: 25767396 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and Toxicity of Different Chemotherapy Regimens in the Treatment of Advanced or Metastatic Pancreatic Cancer: A Network Meta-Analysis. Liu GF; Li GJ; Zhao H J Cell Biochem; 2018 Jan; 119(1):511-523. PubMed ID: 28608558 [TBL] [Abstract][Full Text] [Related]
8. Chemotherapy for colorectal cancer. Goyle S; Maraveyas A Dig Surg; 2005; 22(6):401-14. PubMed ID: 16479107 [TBL] [Abstract][Full Text] [Related]
9. Platinum compounds in the treatment of advanced breast cancer. Martín M Clin Breast Cancer; 2001 Oct; 2(3):190-208; discussion 209. PubMed ID: 11899413 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of Chemotherapy in Patients with Unresectable or Metastatic Pancreatic Acinar Cell Carcinoma: Potentially Improved Efficacy with Oxaliplatin-Containing Regimen. Yoo C; Kim BJ; Kim KP; Lee JL; Kim TW; Ryoo BY; Chang HM Cancer Res Treat; 2017 Jul; 49(3):759-765. PubMed ID: 27857025 [TBL] [Abstract][Full Text] [Related]
11. Rechallenge with cisplatin in a patient with pancreatic cancer who developed a hypersensitivity reaction to oxaliplatin. Is skin test useful in this setting? Elligers KT; Davies M; Sanchis D; Ferencz T; Saif MW JOP; 2008 Mar; 9(2):197-202. PubMed ID: 18326929 [TBL] [Abstract][Full Text] [Related]
13. Novel developments in the use of antimetabolites. Peters GJ Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):358-74. PubMed ID: 24940694 [TBL] [Abstract][Full Text] [Related]
14. A review of systemic therapy for advanced pancreatic cancer. El-Rayes BF; Philip PA Clin Adv Hematol Oncol; 2003 Jul; 1(7):430-4. PubMed ID: 16258429 [TBL] [Abstract][Full Text] [Related]
15. Oral chemotherapy for second-line treatment in patients with gemcitabine-refractory advanced pancreatic cancer. Park SJ; Kim H; Shin K; Lee MA; Hong TH World J Gastrointest Oncol; 2019 Nov; 11(11):1021-1030. PubMed ID: 31798782 [TBL] [Abstract][Full Text] [Related]
16. Pemetrexed in patients with gastrointestinal carcinoma. de Gramont A; Kindler HL Semin Oncol; 2002 Apr; 29(2 Suppl 5):42-9. PubMed ID: 12023792 [TBL] [Abstract][Full Text] [Related]
17. [Has there been progress in the treatment of metastatic pancreatic cancer?]. Jerusalem G; Bours V; Fillet G Rev Med Liege; 2000 Mar; 55(3):146-8. PubMed ID: 10823002 [TBL] [Abstract][Full Text] [Related]
18. Capecitabine: a review. Walko CM; Lindley C Clin Ther; 2005 Jan; 27(1):23-44. PubMed ID: 15763604 [TBL] [Abstract][Full Text] [Related]
19. Phase II trial of selective internal radiation therapy and systemic chemotherapy for liver-predominant metastases from pancreatic adenocarcinoma. Gibbs P; Do C; Lipton L; Cade DN; Tapner MJ; Price D; Bower GD; Dowling R; Lichtenstein M; van Hazel GA BMC Cancer; 2015 Oct; 15():802. PubMed ID: 26503593 [TBL] [Abstract][Full Text] [Related]
20. Is There a Standard Adjuvant Therapy for Resected Pancreatic Cancer? Fenocchio E; Filippi R; Lombardi P; Quarà V; Milanesio M; Aimar G; Leone F; Aglietta M Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31614884 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]